The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Basilea Pharmaceutica Deutschland GmbHEU/1/15/1036/002

Main Information

Trade NameCresemba
Active SubstancesIsavuconazonium sulfate
Dosage FormPowder for concentrate for solution for infusion
Licence HolderBasilea Pharmaceutica Deutschland GmbH
Licence NumberEU/1/15/1036/002

Group Information

ATC CodeJ02AC Triazole derivatives
J02AC05 ZZZ Isavuconazole


License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back